ALNY Snapshot | |
---|---|
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts. | |
VALUATION DATA | |
Market Capitalization | $19,170,869,000 | Price to Sales | 9.00 |
Earnings per Share | $-3.5200 |
PE Ratio | None |
PRICE DATA | |
Most Recent Close | $149.4500 |
52 Week High | $10.49 |
52 Week Low | $142.92 |
50-Day Moving Average | $10.01 |
200-Day Moving Average | $-85.03 |
All data are from Alpha Vantage as of today. For more infomation on ALNY see Stock Dividend, Valuation, Price and Financial Data for Investors |